Literature DB >> 21332470

Functional characterization of the TSC2 c.3598C>T (p.R1200W) missense mutation that co-segregates with tuberous sclerosis complex in mildly affected kindreds.

M Wentink1, M Nellist, M Hoogeveen-Westerveld, B Zonnenberg, D van der Kolk, T van Essen, S-M Park, G Woods, P Cohn-Hokke, W Brussel, E Smeets, A Brooks, D Halley, A van den Ouweland, A Maat-Kievit.   

Abstract

Tuberous sclerosis complex (TSC) is an autosomal dominant disorder characterized by a combination of neurological symptoms and hamartomatous growths, and caused by mutations in the TSC1 and TSC2 genes. Overall, TSC2 mutations are associated with a more severe disease phenotype. We identified the c.3598C>T (R1200W) change in the TSC2 gene in seven different families. The clinical phenotypes in the families were mild, characterized by mild skin lesions, remitting epilepsy and a lack of severe mental retardation or major organ involvement. Functional analysis of the TSC2 R1200W variant, and four other TSC2 missense variants associated with a mild TSC phenotype, confirmed that the changes disrupted the TSC1-TSC2 function. Interestingly however, in each case, the TSC1-TSC2 interaction was not affected by the amino acid substitution.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21332470     DOI: 10.1111/j.1399-0004.2011.01648.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  10 in total

1.  Genotype and cognitive phenotype of patients with tuberous sclerosis complex.

Authors:  Agnies M van Eeghen; Margaux E Black; Margaret B Pulsifer; David J Kwiatkowski; Elizabeth A Thiele
Journal:  Eur J Hum Genet       Date:  2011-12-21       Impact factor: 4.246

2.  Tuberous Sclerosis Complex Genotypes and Developmental Phenotype.

Authors:  Laura S Farach; Deborah A Pearson; John P Woodhouse; Jeremy M Schraw; Mustafa Sahin; Darcy A Krueger; Joyce Y Wu; Elizabeth M Bebin; Philip J Lupo; Kit Sing Au; Hope Northrup
Journal:  Pediatr Neurol       Date:  2019-03-13       Impact factor: 3.372

3.  Graded loss of tuberin in an allelic series of brain models of TSC correlates with survival, and biochemical, histological and behavioral features.

Authors:  Elizabeth Yuan; Peter T Tsai; Emily Greene-Colozzi; Mustafa Sahin; David J Kwiatkowski; Izabela A Malinowska
Journal:  Hum Mol Genet       Date:  2012-06-29       Impact factor: 6.150

4.  The Phenotypic Spectrum of Tuberous Sclerosis Complex: A Canadian Cohort.

Authors:  Daad Alsowat; Robyn Whitney; Stacy Hewson; Puneet Jain; Valerie Chan; Nadia Kabir; Kimberly Amburgey; Damien Noone; Mathieu Lemaire; Blathnaid McCoy; Maria Zak
Journal:  Child Neurol Open       Date:  2021-05-04

5.  Response to everolimus is seen in TSC-associated SEGAs and angiomyolipomas independent of mutation type and site in TSC1 and TSC2.

Authors:  David J Kwiatkowski; Michael R Palmer; Sergiusz Jozwiak; John Bissler; David Franz; Scott Segal; David Chen; Julian R Sampson
Journal:  Eur J Hum Genet       Date:  2015-03-18       Impact factor: 4.246

6.  Severe bleeding complications and multiple kidney transplants in a patient with tuberous sclerosis complex caused by a novel TSC2 missense variant.

Authors:  Stela Živčić-Ćosić; Karin Mayer; Gordana Đorđević; Mark Nellist; Marianne Hoogeveen-Westerveld; Damir Miletić; Sanjin Rački; Hanns-Georg Klein; Zlatko Trobonjača
Journal:  Croat Med J       Date:  2017-12-31       Impact factor: 1.351

7.  Whole exome sequencing identifies a novel intron heterozygous mutation in TSC2 responsible for tuberous sclerosis complex.

Authors:  Yicong Ye; Yong Zeng
Journal:  Sci Rep       Date:  2019-03-14       Impact factor: 4.379

8.  Variants Within TSC2 Exons 25 and 31 Are Very Unlikely to Cause Clinically Diagnosable Tuberous Sclerosis.

Authors:  Rosemary Ekong; Mark Nellist; Marianne Hoogeveen-Westerveld; Marjolein Wentink; Jessica Panzer; Steven Sparagana; Warren Emmett; Natalie L Dawson; Marie Claire Malinge; Rima Nabbout; Caterina Carbonara; Marco Barberis; Sergio Padovan; Marta Futema; Vincent Plagnol; Steve E Humphries; Nicola Migone; Sue Povey
Journal:  Hum Mutat       Date:  2016-01-12       Impact factor: 4.878

9.  Transgenic expression of the N525S-tuberin variant in Tsc2 mutant (Eker) rats causes dominant embryonic lethality.

Authors:  Masatoshi Shiono; Toshiyuki Kobayashi; Riichi Takahashi; Masatsugu Ueda; Chikashi Ishioka; Okio Hino
Journal:  Sci Rep       Date:  2014-08-04       Impact factor: 4.379

10.  Comparison of the functional and structural characteristics of rare TSC2 variants with clinical and genetic findings.

Authors:  Luiz G Dufner Almeida; Santoesha Nanhoe; Andrea Zonta; Mitra Hosseinzadeh; Regina Kom-Gortat; Peter Elfferich; Gerben Schaaf; Annegien Kenter; Daniel Kümmel; Nicola Migone; Sue Povey; Rosemary Ekong; Mark Nellist
Journal:  Hum Mutat       Date:  2019-12-19       Impact factor: 4.878

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.